Health-related quality of life and anxiety and depression in patients diagnosed with cholangiocarcinoma: a prospective cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Health-related quality of life and anxiety and depression in patients diagnosed with cholangiocarcinoma : a prospective cohort study. / Dengso, Kristine Elberg; Hillingsø, Jens; Marcussen, Anne Marie; Thomsen, Thordis.

In: Acta Oncologica, Vol. 56, No. 2, 2017, p. 198-204.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Dengso, KE, Hillingsø, J, Marcussen, AM & Thomsen, T 2017, 'Health-related quality of life and anxiety and depression in patients diagnosed with cholangiocarcinoma: a prospective cohort study', Acta Oncologica, vol. 56, no. 2, pp. 198-204. https://doi.org/10.1080/0284186X.2016.1266088

APA

Dengso, K. E., Hillingsø, J., Marcussen, A. M., & Thomsen, T. (2017). Health-related quality of life and anxiety and depression in patients diagnosed with cholangiocarcinoma: a prospective cohort study. Acta Oncologica, 56(2), 198-204. https://doi.org/10.1080/0284186X.2016.1266088

Vancouver

Dengso KE, Hillingsø J, Marcussen AM, Thomsen T. Health-related quality of life and anxiety and depression in patients diagnosed with cholangiocarcinoma: a prospective cohort study. Acta Oncologica. 2017;56(2):198-204. https://doi.org/10.1080/0284186X.2016.1266088

Author

Dengso, Kristine Elberg ; Hillingsø, Jens ; Marcussen, Anne Marie ; Thomsen, Thordis. / Health-related quality of life and anxiety and depression in patients diagnosed with cholangiocarcinoma : a prospective cohort study. In: Acta Oncologica. 2017 ; Vol. 56, No. 2. pp. 198-204.

Bibtex

@article{8e2604c5f0f14c8285b81b93ae80a54a,
title = "Health-related quality of life and anxiety and depression in patients diagnosed with cholangiocarcinoma: a prospective cohort study",
abstract = "Background: Cholangiocarcinoma (CCA) is a rare cancer associated with a poor prognosis. Psychosocial challenges may negatively affect daily functioning and health-related quality of life (HRQOL). The primary aim was to evaluate HRQOL, and to assess anxiety and depression in these patients.Material and methods: From 93 eligible patients diagnosed with CCA, 76 were included in a prospective cohort over a period of 15 months. Patients answered the European Organization for Research and Treatment of Cancer QLQ C30 (EORTC QLQ C30) and Hospital Anxiety and Depression Scale (HADS) questionnaires at baseline, one, three and six months after initial treatment; defined as radical operation, explorative laparotomy, chemotherapy or drainage of the bile ducts. Scores were compared between the radically operated patients (n = 25) and palliative patients (n = 51; 12 of these had explorative laparotomy), using repeated measures ANOVA and unpaired ANOVA.Results: The groups were similar in demographic characteristics, except for fewer radically operated men (p = 0.015). There was no significant change over time in HRQOL in total or between groups. At baseline nausea and vomiting scores were higher in the palliative group (p = 0.035), and at one month follow-up, the radical group had higher pain scores (p = 0.009). The majority reported normal/mild anxiety and depression throughout the study; there were no differences between the groups.Conclusions: It was not possible to measure any differences between the groups, regarding HRQOL, anxiety or depression, despite the fact that one of the groups had the prospect of total cure. In clinical settings, observed mean changes in HRQOL scores are generally small; probably due to psychological adaptation by patients to changing health status over time.",
author = "Dengso, {Kristine Elberg} and Jens Hillings{\o} and Marcussen, {Anne Marie} and Thordis Thomsen",
year = "2017",
doi = "10.1080/0284186X.2016.1266088",
language = "English",
volume = "56",
pages = "198--204",
journal = "Acta Oncologica, Supplement",
issn = "1100-1704",
publisher = "Taylor & Francis",
number = "2",

}

RIS

TY - JOUR

T1 - Health-related quality of life and anxiety and depression in patients diagnosed with cholangiocarcinoma

T2 - a prospective cohort study

AU - Dengso, Kristine Elberg

AU - Hillingsø, Jens

AU - Marcussen, Anne Marie

AU - Thomsen, Thordis

PY - 2017

Y1 - 2017

N2 - Background: Cholangiocarcinoma (CCA) is a rare cancer associated with a poor prognosis. Psychosocial challenges may negatively affect daily functioning and health-related quality of life (HRQOL). The primary aim was to evaluate HRQOL, and to assess anxiety and depression in these patients.Material and methods: From 93 eligible patients diagnosed with CCA, 76 were included in a prospective cohort over a period of 15 months. Patients answered the European Organization for Research and Treatment of Cancer QLQ C30 (EORTC QLQ C30) and Hospital Anxiety and Depression Scale (HADS) questionnaires at baseline, one, three and six months after initial treatment; defined as radical operation, explorative laparotomy, chemotherapy or drainage of the bile ducts. Scores were compared between the radically operated patients (n = 25) and palliative patients (n = 51; 12 of these had explorative laparotomy), using repeated measures ANOVA and unpaired ANOVA.Results: The groups were similar in demographic characteristics, except for fewer radically operated men (p = 0.015). There was no significant change over time in HRQOL in total or between groups. At baseline nausea and vomiting scores were higher in the palliative group (p = 0.035), and at one month follow-up, the radical group had higher pain scores (p = 0.009). The majority reported normal/mild anxiety and depression throughout the study; there were no differences between the groups.Conclusions: It was not possible to measure any differences between the groups, regarding HRQOL, anxiety or depression, despite the fact that one of the groups had the prospect of total cure. In clinical settings, observed mean changes in HRQOL scores are generally small; probably due to psychological adaptation by patients to changing health status over time.

AB - Background: Cholangiocarcinoma (CCA) is a rare cancer associated with a poor prognosis. Psychosocial challenges may negatively affect daily functioning and health-related quality of life (HRQOL). The primary aim was to evaluate HRQOL, and to assess anxiety and depression in these patients.Material and methods: From 93 eligible patients diagnosed with CCA, 76 were included in a prospective cohort over a period of 15 months. Patients answered the European Organization for Research and Treatment of Cancer QLQ C30 (EORTC QLQ C30) and Hospital Anxiety and Depression Scale (HADS) questionnaires at baseline, one, three and six months after initial treatment; defined as radical operation, explorative laparotomy, chemotherapy or drainage of the bile ducts. Scores were compared between the radically operated patients (n = 25) and palliative patients (n = 51; 12 of these had explorative laparotomy), using repeated measures ANOVA and unpaired ANOVA.Results: The groups were similar in demographic characteristics, except for fewer radically operated men (p = 0.015). There was no significant change over time in HRQOL in total or between groups. At baseline nausea and vomiting scores were higher in the palliative group (p = 0.035), and at one month follow-up, the radical group had higher pain scores (p = 0.009). The majority reported normal/mild anxiety and depression throughout the study; there were no differences between the groups.Conclusions: It was not possible to measure any differences between the groups, regarding HRQOL, anxiety or depression, despite the fact that one of the groups had the prospect of total cure. In clinical settings, observed mean changes in HRQOL scores are generally small; probably due to psychological adaptation by patients to changing health status over time.

U2 - 10.1080/0284186X.2016.1266088

DO - 10.1080/0284186X.2016.1266088

M3 - Journal article

C2 - 28042709

VL - 56

SP - 198

EP - 204

JO - Acta Oncologica, Supplement

JF - Acta Oncologica, Supplement

SN - 1100-1704

IS - 2

ER -

ID: 187263985